Global Drugs for Sinusitis Market 2016 by Sanofi, Bayer AG, AstraZeneca Plc, Merck, Amgen to 2021

drugs-for-sinusitis-marketSinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks.

Access Full Report: http://www.fiormarkets.com/report/global-drugs-for-sinusitis-market-by-manufacturers-regions-14455.html

Scope of the Report:
This report focuses on the Drugs for Sinusitis in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers
Sanofi
Bayer AG
Pfizer
AstraZeneca Plc
Novartis AG.
Johnson & Johnson
Merck
Amgen
Bionorica SE
Dr. Reddy’s Laboratories
Huasun

Request For Sample Report: http://www.fiormarkets.com/report-detail/14455/request-sample

Market Segment by Regions
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type
Antibiotics
Corticosteroids
Decongestants

Market Segment by Applications
Acute Sinusitis
Chronic Sinusitis

There are 13 Chapters to deeply display the global Drugs for Sinusitis market report.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com

Leave a Reply

Designed by CyFocus.com
Powered by CyFocus.net